by alexcastillo | Sep 3, 2020 | MAT Resources
The Mat defines predicted increases in need for behavioral health services during and after the pandemic; defines existing capacity and needed expansion of that capacity; and, outlines needed capacity expansion in an actionable format. Download this...
by alexcastillo | Aug 31, 2020 | MAT Resources
The Medical Advisory Team no longer recommends chloroquine and hydroxychloroquine for the treatment of COVID-19 or SARS-CoV-2 infection, with or without azithromycin. Download this resource
by alexcastillo | Aug 24, 2020 | MAT Resources
The MAT outlines recommendations for Skilled Nursing Facilities, Long-Term Care Facilities, and Assisted Living Facilities related to managing patients/residents who are moving betweenfacilities, including for ancillary and emergency care. Detailed guidance also is...
by alexcastillo | Aug 24, 2020 | MAT Resources
New data has emerged for existing and expanding test methods for detection of SARS-CoV-2. This document provides a summary and recommendation for some of these methods. Rapid molecular point of care tests have emerged and offer significant improvement for near patient...
by alexcastillo | Aug 18, 2020 | MAT Resources
The NM Medical Advisory Team does not recommend ivermectin therapy in patients with COVID-19 infection outside of clinical trials until more data is available. Current evidence for using ivermectin in the treatment of COVID-19 is still largely speculative. There is...
by alexcastillo | Jul 29, 2020 | MAT Resources
New Mexico will not receive enough remdesivir for hospitals to allow every eligible patient to be treated with remdesivir under the Emergency Use Authorization.1 We recommend allocating remdesivir to hospital facilities and patients based on the guidelines provided by...
